| ABCB1/P-gp | ATP-binding cassette transporters B1/P-glycoprotein |
| ACSL6 | Acyl-CoA synthetase long chain family member 6 |
| AD | Alzheimer’s disease |
| ADAS-Cog | AD Assessment Scale–Cognitive Subscale |
| ADME | absorption, distribution, metabolism, excretion |
| ApoE4 | apolipoprotein ε4 |
| APP | amyloïd precursor protein |
| ARA | arachidonic acid |
| AUC | area under the curve |
| Aβ | β-amyloid |
| BBB | blood–brain barrier |
| BCEC | brain capillary endothelial cells |
| CAA | cerebral amyloid angiopathy |
| CAIDE | Cardiovascular Risk Factors, Aging, and Incidence of Dementia |
| CNS | central nervous system |
| CSF | cerebrospinal fluid |
| DHA | docosahexaenoic acid |
| EGCG | epigallocatechin gallate |
| ENS | enteric nervous system |
| EPA | eicosapentaenoic acid |
| FA | fatty acid |
| FAPB5 | fatty acid binding protein 5 |
| GLP-1 | glucagon-like-peptide 1 |
| LRP1 | low-density lipoprotein receptor-related protein 1 |
| MEC | minimum effective concentration |
| MMSE | Mini-Mental State Examination |
| n-3 PUFAs | omega-3 polyunsaturated fatty acids |
| NPs | natural products |
| PD | Parkinson’s disease |
| PK | pharmacokinetic |
| RAGE | receptor for advanced glycation end-products |
| RCT | randomized controlled trial |
| T2D | type 2 diabetes |
| TfR | transferrin receptor. |